Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients
Phase 2
Completed
- Conditions
- Sialorrhea (Excessive Drooling)
- Interventions
- Drug: NH004 Placebo
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2015-12-10
- Lead Sponsor
- NeuroHealing Pharmaceuticals Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01844648
- Locations
- 🇫🇷
Hôpital de la Salpêtrière, Paris, Cedrex 13, France
🇫🇷Hôpital Paul de Viguier, Toulouse, Cedrex 9, France
🇫🇷Hôpital Haut Lévêque, Bordeaux, Pessac, France
Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients
Phase 2
Completed
- Conditions
- Sialorrhea Secondary to Parkinson's Disease
- Interventions
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- NeuroHealing Pharmaceuticals Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT00761137
- Locations
- 🇦🇷
FLENI Hospital, Buenos Aires, Argentina
Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2017-03-31
- Lead Sponsor
- NeuroHealing Pharmaceuticals Inc.
- Target Recruit Count
- 76
- Registration Number
- NCT00761228
- Locations
- 🇺🇸
Spaulding Rehabilitation Hospital, Boston, Massachusetts, United States
News
No news found